4//SEC Filing
A2A Pharmaceuticals, Inc. 4
Accession 0001859061-23-000007
CIK 0001840439other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:00 PM ET
Size
6.8 KB
Accession
0001859061-23-000007
Insider Transaction Report
Form 4
A2A Pharmaceuticals, Inc.
10% Owner
Transactions
- Sale
Common Stock
2023-06-01$34.56/sh−50,000$1,728,165→ 3,500,000 total - Sale
Common Stock
2023-05-31$33.81/sh−75,000$2,535,750→ 3,550,000 total
Footnotes (2)
- [F1]A total of 75,000 shares were sold at an average price of 33.81 in multiple transactions ranging from 33.44 to 34.43. Details of the specific transactions are available upon request.
- [F2]A total of 50,000 shares were sold at an average price of 34.5633 in multiple transactions ranging from 34.50 to 35.02 Details of the specific transactions are available upon request.
Documents
Issuer
Biomea Fusion, Inc.
CIK 0001840439
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001859061
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:00 PM ET
- Size
- 6.8 KB